Myeloma Novel Drug Targets and agents
Impact of novel therapies on the overall survival of patients with multiple myeloma over the past two decades: a real-life single-center study.
Esther Ortega Vida, MD
Resident
Hospital Universitario Jerez de la Frontera
Jerez de la Frontera, Andalucia, Spain